XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss $ (9,324) $ (17,756) $ (23,845) $ (20,288)
Adjustments to reconcile net loss to net cash used in operating activities:        
Stock-based compensation expense 954 1,621 2,396 2,658
Depreciation and amortization 472 500 669 733
Loss on disposal of assets 36 36
Fair value of warrants issued for services 651 452 711 232
Common stock issued for services     20
Accretion of discount on note receivable     (29)
Forgiveness of indebtedness income     (1,265)
Impairment on note receivable     911
Change in fair value of warrant liability, net of issuance costs of $645 (10,362)    
Excess warrant fair value 6,453    
Forgiveness of indebtedness income (1,265)    
Changes in operating assets and liabilities:        
Accounts receivable 229 337 746 228
Operating lease assets and liabilities, net (81) 7 7 548
Tenant improvement allowance 516 516 (516)
Prepaid expenses and other current assets 679 (541) 126 (902)
Deposits 81 (17) (16) (47)
Accounts payable 118 (276) 491 139
Accrued expenses 42 (644) (941) 1,117
Employee retention credit liability 1,220    
Other liabilities 94 261 144
Contract liability (424) 182 638 (539)
Net cash used in operating activities (9,198) (16,587) (19,587) (15,735)
CASH FLOWS FROM INVESTING ACTIVITIES:        
Acquisitions of property and equipment (638) (724) (924) (2,396)
Payment for business acquisition     (225)
Principal collections under note receivable     13
Payment for asset purchase (50)    
Net cash used in investing activities (688) (724) (924) (2,608)
CASH FLOWS FROM FINANCING ACTIVITIES:        
Proceeds from the private placement of common stock and pre-funded warrants 8,000    
Proceeds from issuance of common stock     27,930
Redemption of preferred stock     (1,500)
Payments for issuance costs (645) (2,238)
Principal payments on debt     (25)
Net cash provided by financing activities 7,355 24,167
Net decrease in cash and cash equivalents (2,531) (17,311) (20,511) 5,824
Cash and cash equivalents at beginning of year 3,519 24,030 24,030 18,206
Cash and cash equivalents at end of year 988 6,719 3,519 24,030
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:        
Cash paid for interest 2 2 18
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND        
Fair value of warrants issued in asset purchase $ 116 136
Fair value of warrants issued in business acquisition     172
Fair value of warrants issued to underwriters in connection with follow-on offering     1,486
Capital expenditures included in accounts payable     $ 110